These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16358238)

  • 1. Association of IgA nephropathy, hypothyroidism and hypercholesterolemia.
    Deák G; Ruzicska E; Somogyi A
    J Nephrol; 2005; 18(6):773-6. PubMed ID: 16358238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible renal insufficiency, hyperuricemia and gouty arthritis in a case of hypothyroidism.
    Mooraki A; Bastani B
    Clin Nephrol; 1998 Jan; 49(1):59-61. PubMed ID: 9491289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperperfusion injury in IgA nephropathy.
    Nagy J; Magyarlaki T; Háber A; Kun L; Bohle A
    Acta Morphol Hung; 1991; 39(4):299-307. PubMed ID: 1844342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between hypothyroidism and cholesterol out of the records of 1756 patients].
    Sampaolo G; Campanella N; Catozzo V; Ferretti M; Vichi G; Morosini P
    Recenti Prog Med; 2014 Feb; 105(2):79-82. PubMed ID: 24625905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of thyroid substitution on hypercholesterolaemia in patients with subclinical hypothyroidism: a reanalysis of intervention studies.
    Tanis BC; Westendorp GJ; Smelt HM
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):643-9. PubMed ID: 8759176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behcet's disease and IgA nephropathy: report of this association in a patient from Brazil and literature review.
    Fernandes PF; Júnior GB; Barros FA; Sousa DC; Franco LM; Patrocínio RM
    Invest Clin; 2006 Dec; 47(4):405-11. PubMed ID: 17176908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation.
    Tang Z; Ji SM; Chen DR; Wen JQ; Chen JS; Liu ZH; Li LS
    Ren Fail; 2008; 30(6):611-6. PubMed ID: 18661411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
    Trimarchi H; Muryan A; Young P; Forrester M; Iotti A; Pereyra H; Lombi F; Seminario O; Alonso M; Iotti R
    Medicina (B Aires); 2007; 67(5):445-50. PubMed ID: 18051227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic correlation in IgA nephropathy.
    Philibert D; Cattran D; Cook T
    Semin Nephrol; 2008 Jan; 28(1):10-7. PubMed ID: 18222342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
    Manno C; Strippoli GF; D'Altri C; Torres D; Rossini M; Schena FP
    Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing thyroxine requirements in primary hypothyroidism: don't forget the urinalysis!
    Junglee NA; Scanlon MF; Rees DA
    J Postgrad Med; 2006; 52(3):201-3. PubMed ID: 16855322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary excretion of low-molecular-weight proteins as prognostic markers in IgA nephropathy.
    Peters HP; van den Brand JA; Wetzels JF
    Neth J Med; 2009 Feb; 67(2):54-61. PubMed ID: 19299847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypothyroidism, hypocholesteremic agents and rhabdomyolysis].
    Gouton M
    Arch Mal Coeur Vaiss; 1993 Dec; 86(12):1761-4. PubMed ID: 8024378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study.
    Iqbal A; Jorde R; Figenschau Y
    J Intern Med; 2006 Jul; 260(1):53-61. PubMed ID: 16789979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Subclinical hypothyroidism].
    Krysiak R; Marek B; Okopień B
    Wiad Lek; 2008; 61(4-6):139-45. PubMed ID: 18939365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory markers and the progression of IgA glomerulonephritis.
    Kaartinen K; Syrjänen J; Pörsti I; Hurme M; Harmoinen A; Pasternack A; Huhtala H; Mustonen J
    Nephrol Dial Transplant; 2008 Apr; 23(4):1285-90. PubMed ID: 17986475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease.
    Roos A; Rastaldi MP; Calvaresi N; Oortwijn BD; Schlagwein N; van Gijlswijk-Janssen DJ; Stahl GL; Matsushita M; Fujita T; van Kooten C; Daha MR
    J Am Soc Nephrol; 2006 Jun; 17(6):1724-34. PubMed ID: 16687629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of sex in primary glomerulonephritis.
    Cattran DC; Reich HN; Beanlands HJ; Miller JA; Scholey JW; Troyanov S;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2247-53. PubMed ID: 18182409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance and the progression of IgA glomerulonephritis.
    Kaartinen K; Syrjänen J; Pörsti I; Harmoinen A; Pasternack A; Huhtala H; Niemelä O; Mustonen J
    Nephrol Dial Transplant; 2007 Mar; 22(3):778-83. PubMed ID: 17166857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.